Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs.
about
Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell TherapyBrazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liverReview article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitisReview article: the management of autoimmune hepatitis beyond consensus guidelinesReview article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targetsDiagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsLiver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.Review article: autoimmune hepatitis -- current management and challenges.Challenges in the diagnosis and management of autoimmune hepatitis.Acute and acute severe (fulminant) autoimmune hepatitis.Autoimmune hepatitis in diverse ethnic populations and geographical regions.Current and prospective pharmacotherapy for autoimmune hepatitis.Evolving paradigm of treatment for autoimmune hepatitis.Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba.Refractory Autoimmune Hepatitis: Beyond Standard Therapy.Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype.High affinity anti-BSEP antibodies after liver transplantation for PFIC-2 - Successful treatment with immunoadsorption and B-cell depletion.Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis: A systematic review and network meta-analysis.
P2860
Q26742101-46F5FCC3-17A2-4094-A4A3-450E7D9C0CE8Q26766699-357801DD-809D-4B80-8873-A29C23423C7BQ26827599-310D1316-EBB8-4A88-A009-A924F0E5C132Q26864272-283F8ED8-104F-4FAF-903F-826725EF8C0AQ27025680-955C1139-C322-4D15-B2D2-F8734F16E887Q28076505-3AA39019-2740-48E9-A0C2-88DFB5FD5C6BQ33424303-0644776A-080A-4AD4-8A55-C38E82F9B6B7Q34369116-3B13E19E-B319-46EB-94BB-2A48A4A636CDQ37640582-3388BACF-B036-4A24-94E6-4F83C584095FQ38054513-98417306-F549-4786-A80A-297A90618473Q38103631-017712A6-BD76-4B25-8476-F1870079C8AEQ38222882-BD48A423-9E3A-4402-80E3-E3F8B124FBA8Q38730872-979E76C3-149D-4DE9-A97A-584A9C33D405Q38902371-8DE62015-1A7F-4EAB-9958-E9B1790CB70DQ44247097-02846B3E-06D0-4890-B1D9-BC31FD8A5F88Q46408372-932E108C-297B-4E16-AFA7-84011AC36A8EQ51031338-60C7E69E-99AC-42A3-ACDA-3215DCDC57B1Q51668984-B72CA7D3-BE49-447F-A966-BFB4B0AB79D1Q55428911-F737D498-6E4F-40EC-AE37-C5E676056482
P2860
Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Systematic review: managing su ...... ntional and nonstandard drugs.
@ast
Systematic review: managing su ...... ntional and nonstandard drugs.
@en
Systematic review: managing su ...... ntional and nonstandard drugs.
@nl
type
label
Systematic review: managing su ...... ntional and nonstandard drugs.
@ast
Systematic review: managing su ...... ntional and nonstandard drugs.
@en
Systematic review: managing su ...... ntional and nonstandard drugs.
@nl
prefLabel
Systematic review: managing su ...... ntional and nonstandard drugs.
@ast
Systematic review: managing su ...... ntional and nonstandard drugs.
@en
Systematic review: managing su ...... ntional and nonstandard drugs.
@nl
P2860
P356
P1476
Systematic review: managing su ...... entional and nonstandard drugs
@en
P2093
V Selvarajah
P2860
P304
P356
10.1111/APT.12042
P407
P577
2012-09-13T00:00:00Z